Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Congyi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Carbon Monoxide, Polyethylene Glycols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Harbin Medical University, Heilongjiang Provincial Postdoctoral Science Foundation.
Abstract (Originalsprache)
In recent years, carbon monoxide (CO) has garnered increased attention as a novel green therapy for hepatocellular carcinoma (HCC) treatment. However, the CO donor is still limited in clinical application due to its lack of targeted ability and unstable release rate. Here, self-assembled amphiphilic nanomicelles glucose-polyethylene glycol (PEG)-lipoic acid (LA)-Fe2(CO)6 (Glu-Fe2(CO)6) are first designed as a CO donor and synthesized via a chemical method, combining glucose with Fe2(CO)6 through PEG-LA. Some advantages of this tumor-targeted Glu-Fe2(CO)6 delivery system include (I) good water-solubility, (II) the glutathione responsive CO slow release, (III) the active tumor-targeted ability of glucose as targeted ligands, and (IV) outstanding efficacy of antitumor and safety of CO therapy of HCC both in vitro and in vivo. These findings suggest that Glu-Fe2(CO)6 nanomicelles hold promise for enhancing antitumor therapeutic capabilities, presenting a novel tumor-targeted delivery strategy in gas therapy for HCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
- Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150081, China.
- Department of Pharmaceutics, Harbin Medical University-Daqing Campus, 1 Xinyang Road, Daqing 163319, China.
- Department of Biomedical and Life Science, Institute of Life Sciences & Medicine, King's College London, London SE1 1UL, U.K.
ORCID-Profile: Wenhua Li
Förderung
- China Postdoctoral Science Foundation
- Harbin Medical University
- Heilongjiang Provincial Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Huang, S., Ding, K., Wu, H., Li, M., Li, T., Shen, Z., Tai, S., & Li, W. (2024). Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00437
Vancouver
Zhang C, Huang S, Ding K, Wu H, Li M, Li T, et al. Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00437
BibTeX
@article{Zhang2024,
author = {Zhang, Congyi and Huang, Shizhuan and Ding, Kunhao and Wu, Haotian and Li, Minghui and Li, Tianwei and Shen, Zibo and Tai, Sheng and Li, Wenhua},
title = {Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00437}
}
EUVIMED